RDUS radiuspharm.com Earnings growth forecast for next year

Corporate emblem and logo of Radius Recycling (RDUS)

Radius Recycling, Inc. (RDUS) is optimizing component supplies for metabolic therapy through hub diversification. Stable turnover is driven by secondary metal recycling, while rising R&D expenditures accompany clinical drug trials. The promising EPS n+1 growth metric on the GURU.Markets chart reflects market expectations, where the value 110.10 indicates the current projected profit for the coming year.

Radius Health (RDUS): Expected net earnings per share growth next year from 07/04/2022 to 07/26/2025

RDUS (Radius Recycling Inc.): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Initial company analysis:RDUS, radiuspharm.com
Finished products of Radius Recycling

Radius Recycling, Inc. (RDUS) is expanding its presence in the osteoporosis and metabolic disorder treatment segment, aiming to increase its share of the US pharmaceutical market. This forward-looking assessment of net profit dynamics visualizes the analysts' consensus earnings per share (EPS) forecast, transforming complex models into a daily trend that allows for an evaluation of the B2B distribution scaling strategy's effectiveness and the business's fundamental resilience.

Analysis of competing companies

ASND (Ascendis) - Earnings growth forecast for next year|Earnings growth forecast for next year Madrigal Pharmaceuticals|Earnings growth forecast for next year CORT|Net earnings per share growth forecast for next year RYTM (Rhythm Pharma)|Net earnings per share growth forecast for next year akerotx.com AKRO|Metsera Therapeutics (MTSR) - Expected net earnings per share growth next year|MLTX - Net earnings per share growth forecast for next year|CRNX: Net earnings per share growth forecast for next year|NAMS: Earnings growth forecast for next year|SLNO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Amicus Corp|89bio Pharma (ETNB) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agios.com (AGIO)|Expected earnings per share growth for next year structuretx.com GPCR|Net earnings per share growth forecast for next year MiMedx Group Inc MDXG|Expected earnings per share trend next year RZLT|lexpharma.com - Earnings growth forecast for next year|MBX (MBX Biosciences Inc) - Projected earnings per share growth rate for next year|ALT: Earnings growth forecast for next year|Aardvark Therapeutics Inc - Expected earnings per share trend next year|SGMT (Sagimet Biosciences, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year BioAge|Earnings growth forecast for next year BMEA|Expected earnings per share growth for next year Quince Therapeutics, Inc. QNCX|Fractyl Health Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year VTVT|Agape ATP Corporation - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Pluri PLUR|SYBX: Earnings growth forecast for next year|Expected net earnings per share growth next year Lipocine Inc. (LPCN)|MTNB (Matinas BioPharma) - Earnings growth forecast for next year|sprucebiosciences.com (SPRB) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Galecto Corp (GLTO)|CTCX - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Lumos Therapeutics LUMO|Organovo Corp (ONVO) - Expected net earnings per share growth next year